ATE294178T1 - Spiro verbindungen mit antihistaminischer aktivität - Google Patents

Spiro verbindungen mit antihistaminischer aktivität

Info

Publication number
ATE294178T1
ATE294178T1 AT99964625T AT99964625T ATE294178T1 AT E294178 T1 ATE294178 T1 AT E294178T1 AT 99964625 T AT99964625 T AT 99964625T AT 99964625 T AT99964625 T AT 99964625T AT E294178 T1 ATE294178 T1 AT E294178T1
Authority
AT
Austria
Prior art keywords
spiro compounds
antihistaminic activity
antihistaminic
activity
spiro
Prior art date
Application number
AT99964625T
Other languages
English (en)
Inventor
Frans Eduard Janssens
Joseph Elisabeth Leenaerts
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE294178T1 publication Critical patent/ATE294178T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Dental Preparations (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99964625T 1998-12-19 1999-12-15 Spiro verbindungen mit antihistaminischer aktivität ATE294178T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204347 1998-12-19
PCT/EP1999/010176 WO2000037470A1 (en) 1998-12-19 1999-12-15 Antihistaminic spiro compounds

Publications (1)

Publication Number Publication Date
ATE294178T1 true ATE294178T1 (de) 2005-05-15

Family

ID=8234498

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99964625T ATE294178T1 (de) 1998-12-19 1999-12-15 Spiro verbindungen mit antihistaminischer aktivität

Country Status (37)

Country Link
US (2) US7148214B1 (de)
EP (1) EP1144411B1 (de)
JP (1) JP4601175B2 (de)
KR (1) KR100598725B1 (de)
CN (1) CN1258533C (de)
AR (1) AR021888A1 (de)
AT (1) ATE294178T1 (de)
AU (1) AU764820C (de)
BG (1) BG65133B1 (de)
BR (1) BR9916371A (de)
CA (1) CA2355939C (de)
CO (1) CO5140116A1 (de)
CZ (1) CZ301953B6 (de)
DE (1) DE69925036T2 (de)
DK (1) DK1144411T3 (de)
EA (1) EA004500B1 (de)
EE (1) EE04917B1 (de)
EG (1) EG24605A (de)
ES (1) ES2242443T3 (de)
HK (1) HK1043128B (de)
HR (1) HRP20010453B1 (de)
HU (1) HU229406B1 (de)
ID (1) ID29268A (de)
IL (1) IL143767A0 (de)
MY (1) MY129663A (de)
NO (1) NO318891B1 (de)
NZ (1) NZ512870A (de)
PL (1) PL196262B1 (de)
PT (1) PT1144411E (de)
SA (1) SA00210113B1 (de)
SI (1) SI1144411T1 (de)
SK (1) SK286158B6 (de)
TR (1) TR200101711T2 (de)
TW (1) TWI250981B (de)
UA (1) UA74537C2 (de)
WO (1) WO2000037470A1 (de)
ZA (1) ZA200104977B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2462374C (en) * 2001-10-15 2011-01-18 Janssen Pharmaceutica N.V. Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
JP4417108B2 (ja) * 2001-10-15 2010-02-17 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 新規な置換された4−フェニル−4−[1h−イミダゾール−2−イル]−ピペリジン誘導体および選択的非ペプチドデルタオピオイドアゴニストとしてのそれらの使用
EP1765052A4 (de) * 2004-05-11 2012-06-20 George E Alliss Pflanzentrimmer
CA2579204A1 (en) * 2004-09-07 2006-03-16 Banyu Pharmaceutical Co., Ltd. Carbamoyl-substituted spiro derivative
EP2285808B1 (de) 2008-04-29 2013-11-20 Novartis AG Spiro-indolderivate zur behandlung parasitischer krankheiten
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EP3964507A1 (de) 2013-10-04 2022-03-09 Infinity Pharmaceuticals, Inc. Heterocyclische verbindungen und verwendungen davon
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN106456628A (zh) 2014-03-19 2017-02-22 无限药品股份有限公司 用于治疗PI3K‑γ介导的障碍的杂环化合物
BR112017003745A2 (pt) 2014-08-29 2017-12-05 Tes Pharma S R L inibidores de semialdeído descarboxilase de ácido alfa-amino-beta-carboximucônico
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN114230571B (zh) 2015-09-14 2025-07-08 无限药品股份有限公司 异喹啉酮的固体形式、其制备方法、包含其的组合物及其使用方法
WO2017088080A1 (es) 2015-11-25 2017-06-01 Natural Response S.A. Método para la obtención de saponinas a partir de plantas
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
US10919914B2 (en) 2016-06-08 2021-02-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
KR102806793B1 (ko) 2022-10-14 2025-05-12 지이 일렉트리컬 엔지니어링 컴퍼니., 리미티드. 여과 장치
KR102806794B1 (ko) 2022-10-14 2025-05-12 지이 일렉트리컬 엔지니어링 컴퍼니., 리미티드. 여과 장치용 커버
CN117624052B (zh) * 2024-01-26 2024-04-12 四川益能康生环保科技有限公司 一种用于捕集二氧化碳的离子液体及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464380A (en) 1983-05-25 1984-08-07 Pfizer Inc. Imidazolidinedione derivatives
PH30434A (en) * 1989-04-07 1997-05-09 Janssen Pharmaceutica Nv Hydroxyalkylfuranyl derivatives
EP0552292B1 (de) * 1990-10-10 1995-06-21 Schering Corporation Substituierte imidazobenzazepine und imidazopyridoazepine
IL101851A (en) * 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv 10-(4-piperidinyl- and piperidinylidene)-imidazo [1,2-a] (pyrrolo thieno or furano) [2,3] azepine derivatives their preparation and pharmaceutical compositions containing them and certain novel intermediates therefor
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv 11-(4-Piperidinyl)-imidazo (2,1-b) (3) benzazepine derivatives their preparation and pharmaceutical compositions containing them
US5106844A (en) * 1991-09-10 1992-04-21 Sterling Drug Inc. Imidazo[2,2-b][3]benzazepine and pyrimido[2,1-b][3]benzazepine antiarrhythmic agents
TW382017B (en) * 1995-12-27 2000-02-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives

Also Published As

Publication number Publication date
EA200100681A1 (ru) 2001-12-24
JP4601175B2 (ja) 2010-12-22
SI1144411T1 (en) 2005-10-31
WO2000037470A8 (en) 2000-08-24
HUP0104779A2 (hu) 2002-04-29
PL196262B1 (pl) 2007-12-31
HK1043128A1 (en) 2002-09-06
NO20012710D0 (no) 2001-06-01
ES2242443T3 (es) 2005-11-01
TWI250981B (en) 2006-03-11
HUP0104779A3 (en) 2003-12-29
EE04917B1 (et) 2007-10-15
KR20010075655A (ko) 2001-08-09
AU764820C (en) 2004-11-18
EP1144411A1 (de) 2001-10-17
KR100598725B1 (ko) 2006-07-11
AR021888A1 (es) 2002-08-07
ID29268A (id) 2001-08-16
EP1144411B1 (de) 2005-04-27
PT1144411E (pt) 2005-09-30
SA00210113B1 (ar) 2006-09-13
CN1331694A (zh) 2002-01-16
NZ512870A (en) 2003-11-28
HRP20010453A2 (en) 2002-06-30
BR9916371A (pt) 2001-09-18
NO20012710L (no) 2001-06-01
PL348295A1 (en) 2002-05-20
HK1043128B (zh) 2007-01-19
BG65133B1 (bg) 2007-03-30
TR200101711T2 (tr) 2001-12-21
CN1258533C (zh) 2006-06-07
DE69925036T2 (de) 2006-01-26
US7148214B1 (en) 2006-12-12
JP2002533344A (ja) 2002-10-08
CZ20012069A3 (cs) 2002-02-13
UA74537C2 (uk) 2006-01-16
ZA200104977B (en) 2002-06-18
EE200100328A (et) 2002-08-15
SK286158B6 (sk) 2008-04-07
EG24605A (en) 2010-01-10
DE69925036D1 (de) 2005-06-02
AU764820B2 (en) 2003-08-28
HRP20010453B1 (hr) 2010-07-31
WO2000037470A1 (en) 2000-06-29
HU229406B1 (en) 2013-12-30
MY129663A (en) 2007-04-30
EA004500B1 (ru) 2004-04-29
CA2355939C (en) 2010-12-14
DK1144411T3 (da) 2005-09-19
SK8142001A3 (en) 2002-04-04
CO5140116A1 (es) 2002-03-22
NO318891B1 (no) 2005-05-18
US7087595B2 (en) 2006-08-08
CA2355939A1 (en) 2000-06-29
US20050026901A1 (en) 2005-02-03
AU3041200A (en) 2000-07-12
IL143767A0 (en) 2002-04-21
BG105546A (en) 2001-12-29
CZ301953B6 (cs) 2010-08-11

Similar Documents

Publication Publication Date Title
IS6267A (is) Ný spíróefnasambönd
DE69925036D1 (de) Spiro verbindungen mit antihistaminischer aktivität
DE69905038D1 (de) Cyclische boroprolinverbindungen
DE60031682D1 (de) Antibakterielle verbindungen
BR9909681B1 (pt) estrutura de seringa.
DE69733649D1 (de) Calcylitische verbindungen
DE69005858D1 (de) Heterocyclische Verbindungen.
IT1308096B1 (it) Convertiplano
EP0746326A4 (de) Oiligomere verbindungen mit stickstoff enthaltenden verbindungen
ATE222893T1 (de) Triazinylaminostilben verbindungen
ATE283049T1 (de) Antibakterielle verbindungen
DE69808403D1 (de) Tetradecachlorcyclohexasilandianon enthaltende Verbindungen
DE60033071D1 (de) Triazospiroverbindungen mit nociceptin-rezeptoraffinität
ATE405580T1 (de) Antithrombotische verbindungen
DE69806792D1 (de) Photochrome spiro(indolin) fluoranthenoxazine verbindungen
ATE258921T1 (de) Aryl-annellierte azapolycyclische verbindungen
MXPA01011760A (es) Compuestos novedosos de difeniletileno.
DE69531522D1 (de) Heterozyklische Verbindungen
NO20013769D0 (no) Kalsilytiske forbindelser
DE69801556D1 (de) Spirocyclische Verbindungen
ATE225364T1 (de) Bromotiacumicin verbindungen
EP1053307A4 (de) Podocalyxin-ähnliche sialomucine mit selektin-ligand aktivität
DE59811182D1 (de) Heterocyclische Verbindungen
DE69702094D1 (de) N-Acetonylbenzamidverbindungen mit fungizider Aktivität
IT1299046B1 (it) Iniettore per coiniezione

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1144411

Country of ref document: EP